[Experimental studies on the combined effect of cyclophosphamide and 5-fluorouracil on sarcoma 180 depending on dosage and timing].
D000818:Animals; D000970:Antineoplastic Agents; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003864:Depression, Chemical; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D051379:Mice; D012510:Sarcoma 180 / Q000188:drug therapy*; D013268:Stimulation, Chemical; D013997:Time Factors
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil
Experimentelle Untersuchungen zur Kombinationswirkung von Cyclophosphamid und 5-Fluoruracil am Sarkom 180 in Abhängigkeit von Dosierung und Timing.